Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001

被引：0
|
作者：
Solanki, Abhishek A. [1 ]
Kates, Max R. [2 ,3 ]
Tran, Phuoc T. [4 ]
机构：
[1] Loyola Univ Chicago, Dept Radiat Oncol, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL USA
[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Greenberg Bladder Canc Inst, Baltimore, MD USA
[4] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD USA
来源：
EUROPEAN UROLOGY | 2022年 / 82卷 / 03期
基金：
美国国家卫生研究院;
关键词：
RADIATION-THERAPY; RADIOTHERAPY; CHEMOTHERAPY; OUTCOMES;
D O I：
10.1016/j.eururo.2022.05.009
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：280 / 282
页数：3
相关论文
共 50 条
  • [1] Re: Chemoradiotherapy in Muscle-invasive Bladder Cancer (BC2001): 10-year Follow-up of a Phase 3 Randomised Controlled Trial
    Adeleke, Sola
    Tocco, Boris
    Kasivisvanathan, Veeru
    EUROPEAN UROLOGY, 2022, 82 (03) : 329 - 330
  • [2] Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial
    Hall, Emma
    Hussain, Syed A.
    Porta, Nuria
    Lewis, Rebecca
    Crundwell, Malcolm
    Jenkins, Peter
    Rawlings, Christine
    Tremlett, Jean
    Sreenivasan, Thiagarajan
    Wallace, Jan
    Syndikus, Isabel
    Sheehan, Denise
    Lydon, Anna
    Huddart, Robert
    James, Nicholas
    EUROPEAN UROLOGY, 2022, 82 (03) : 273 - 279
  • [3] Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study
    Grabenbauer, Felix
    Flentje, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (04) : 425 - 427
  • [4] Concurrent Chemoradiotherapy for Muscle-invasive Bladder Cancer Using Weekly Cisplatin or Capecitabine and Mitomycin C - A Review of Practice Post BC2001
    Rackley, T.
    Vines, L.
    Palaniappan, N.
    Staffurth, J.
    Button, M.
    Tanguay, J.
    CLINICAL ONCOLOGY, 2014, 26 (02) : E6 - E7
  • [5] MRI Follow-up of Patients Undergoing Concurrent Chemoradiotherapy in Muscle-invasive Bladder Cancer (MIBC)
    Anandadas, C. N.
    Swindell, R.
    Cowan, R. A.
    Carrington, B. M.
    Bonington, S. C.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S28 - S28
  • [6] Organerhaltende Therapie des muskelinvasiven Blasenkarzinoms: 10-Jahres-Daten der britischen BC2001-StudieOrgan-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study
    Felix Grabenbauer
    Michael Flentje
    Strahlentherapie und Onkologie, 2023, 199 (4) : 425 - 427
  • [7] Transurethral resection of muscle-invasive bladder cancer: 10-year outcome
    Herr, HW
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 89 - 93
  • [8] Organ preservation strategies in bladder cancer and the results of BC2001 trial, a Phase III trial of chemoradiotherapy in muscle invasive bladder cancer
    Hussain, Syed A.
    James, Nicholas D.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S82 - S82
  • [9] Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial
    Hussain, Syed A.
    Porta, Nuria
    Hall, Emma
    Salawu, Abdulazeez
    Lewis, Rebecca
    Sreenivasan, Thiagarajan
    Wallace, Jan
    Crundwell, Malcolm
    Jenkins, Peter
    Tremlett, Jean
    Huddart, Robert
    James, Nicholas D.
    EUROPEAN UROLOGY, 2021, 79 (02) : 307 - 315
  • [10] Long term follow-up after radiotherapy for muscle-invasive bladder cancer
    Cooke, PW
    Wallace, DMA
    Dunn, J
    Bathers, S
    Latief, T
    James, ND
    BRITISH JOURNAL OF CANCER, 1998, 78 : 10 - 10
12345